Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA replication in microorganisms involves a highly regulated, semiconservative process mediated by a multi-enzyme **machinery** (replisome) that duplicates the organism's genetic material before cell division. In bacteria, DNA replication begins at a specific **origin of replication** (oriC in *E. coli*), involves the unwinding of supercoiled DNA by **DNA gyrase** (topoisomerase II) and **helicase**, stabilization of single strands by **single-stranded binding proteins**, primer synthesis by **primase**, and extension by **DNA polymerase III** (leading strand continuous, lagging strand as Okazaki fragments). RNA primers are replaced by **DNA polymerase I** and DNA ends are joined by **DNA ligase**. Termination requires decatenation by topoisomerase IV. This process is essential for cellular proliferation. It is a **therapeutic target** for many antibiotics and anti-infectives, particularly those inhibiting bacterial DNA gyrase or polymerases, making it central in **infection therapy and resistance**[1][2][3][4][5][6]. **Important note:** For structured database mapping, individual **enzymes** or complexes (e.g., bacterial DNA gyrase, DNA polymerase III) should be used rather than the broad process "Microorganism DNA replication," which is conceptually correct but not specific to a molecular target[1][2][3][4].
Inhibition of DNA gyrase/topoisomerase II—preventing DNA supercoiling - Inhibition of DNA polymerases—blocking DNA chain elongation - Induction of double-strand breaks in DNA - Formation of aberrant DNA structures leading to cell death
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA replication machinery (microorganism).